CS
SLXP

Credit Suisse’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Credit Suisse’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,800
Closed -$962K – 4835
2014
Q2 		$962K Buy
+7,800
New +$862K ﹤0.01% 3316

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Credit Suisse's SLXP Position: Q2 2015 in Review

Credit Suisse sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 182,992 shares — an estimated $31.6M sold.

Credit Suisse first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $31.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Credit Suisse reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Credit Suisse sold 182,992 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $31.6M.
  • Credit Suisse first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Credit Suisse's SALIX PHARMACEUTICALS LTD DEL position peaked at $31.6M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.